Inhibition of interferon I induction by non-structural protein NSs of Puumala virus and other vole-associated orthohantaviruses: phenotypic plasticity of the protein and potential functional domains.
A549 Cells
Adaptation, Physiological
Animals
Chlorocebus aethiops
Gene Expression Regulation, Viral
Germany
HEK293 Cells
Hemorrhagic Fever with Renal Syndrome
Host-Pathogen Interactions
/ physiology
Humans
Interferon Type I
/ genetics
Interferon-beta
/ genetics
Mutation
Promoter Regions, Genetic
Puumala virus
/ isolation & purification
Vero Cells
Viral Nonstructural Proteins
/ chemistry
Virus Replication
Journal
Archives of virology
ISSN: 1432-8798
Titre abrégé: Arch Virol
Pays: Austria
ID NLM: 7506870
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
30
06
2020
accepted:
14
05
2021
pubmed:
15
8
2021
medline:
16
10
2021
entrez:
14
8
2021
Statut:
ppublish
Résumé
The orthohantavirus Puumala virus (PUUV), which is transmitted by bank voles (Clethrionomys glareolus), and other vole-borne hantaviruses contain in their small (S) genome segment two overlapping open reading frames, coding for the nucleocapsid protein and the non-structural protein NSs, a putative type I interferon (IFN-I) antagonist. To investigate the role of NSs of PUUV and other orthohantaviruses, the expression pattern of recombinant NSs constructs and their ability to inhibit human IFN-I promoter activity were investigated. The NSs proteins of PUUV and related cricetid-borne orthohantaviruses showed strong inhibition of IFN-I promoter induction. We identified protein products originating from three and two methionine initiation codons in the NSs ORF of PUUV during transfection and infection, respectively. The three putative start codons are conserved in all PUUV strains analysed. Translation initiation at these start codons influenced the inhibitory activity of the NSs products, with the wild-type (wt) construct expressing two proteins starting at the first and second methionine and showing strong inhibition activity. Analysis of in vitro-generated variants and naturally occurring PUUV NSs proteins indicated that amino acid variation in the NSs protein is well tolerated, suggesting its phenotypic plasticity. The N-terminal 20-amino-acid region of the NSs protein was found to be associated with strong inhibition and to be highly vulnerable to amino acid exchanges and tag fusions. Infection studies using human, bank vole, and Vero E6 cells did not show obvious differences in the replication capacity of PUUV Sotkamo wt and a strain with a truncated NSs protein (NSs21Stop), showing that the lack of a full-length NSs might be compensated by its N-terminal peptide, as seen in transfection experiments. These results contribute to our understanding of virus-host interactions and highlight the importance of future innate immunity studies in reservoir hosts.
Identifiants
pubmed: 34389893
doi: 10.1007/s00705-021-05159-y
pii: 10.1007/s00705-021-05159-y
pmc: PMC8362652
doi:
Substances chimiques
Interferon Type I
0
Viral Nonstructural Proteins
0
Interferon-beta
77238-31-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2999-3012Subventions
Organisme : Bundesministerium für Bildung und Forschung
ID : 01KI1721A
Organisme : Umweltbundesamt
ID : 370941401
Organisme : Umweltbundesamt
ID : 371348401
Organisme : Friedrich-Loeffler-Institut
ID : HR-0012
Informations de copyright
© 2021. The Author(s).
Références
J Virol. 2009 May;83(9):4365-75
pubmed: 19211744
Int Rev Immunol. 2002 Jul-Oct;21(4-5):305-37
pubmed: 12486817
Virology. 2015 May;479-480:110-21
pubmed: 25749629
J Med Virol. 2007 Oct;79(10):1527-36
pubmed: 17705180
Arch Virol. 2010;155(1):117-21
pubmed: 19956987
Viruses. 2011 Jun;3(6):629-58
pubmed: 21994750
Eur J Cell Biol. 2015 Jul-Sep;94(7-9):384-90
pubmed: 26095300
Trends Microbiol. 2015 Mar;23(3):154-63
pubmed: 25572883
Viruses. 2020 Apr 17;12(4):
pubmed: 32316667
J Virol Methods. 2019 Dec;274:113729
pubmed: 31513859
J Virol. 2020 Jun 16;94(13):
pubmed: 32321811
J Virol. 2013 Apr;87(7):3710-8
pubmed: 23325696
Arch Virol. 2002 Apr;147(4):665-82
pubmed: 12038679
Sci Rep. 2016 Jan 19;6:19234
pubmed: 26781591
J Gen Virol. 2010 Aug;91(Pt 8):2002-2006
pubmed: 20427562
Mol Cell Biol. 1989 Nov;9(11):5073-80
pubmed: 2601709
J Virol. 2012 Feb;86(4):2176-87
pubmed: 22156529
Pathogens. 2020 Jul 08;9(7):
pubmed: 32650456
J Virol. 2005 Jun;79(12):7673-81
pubmed: 15919920
Bioessays. 1985 Jul;3(1):27-31
pubmed: 3024631
Rev Med Virol. 2013 Jan;23(1):35-49
pubmed: 22761056
J Virol. 2002 Aug;76(16):7949-55
pubmed: 12133999
J Virol. 2004 Sep;78(18):9798-806
pubmed: 15331713
Viruses. 2015 Oct 22;7(10):5476-88
pubmed: 26506370
Cell Rep. 2020 Sep 22;32(12):108185
pubmed: 32941788
J Virol Methods. 2006 Jul;135(1):26-31
pubmed: 16504312
Viruses. 2016 Jul 23;8(7):
pubmed: 27455310
Trends Microbiol. 2000 Feb;8(2):61-7
pubmed: 10664598
J Biol Chem. 2004 Jul 23;279(30):31471-7
pubmed: 15150262
Viruses. 2021 Jan 19;13(1):
pubmed: 33478127